Загрузка...
Genetic Engineering and Manufacturing of Hematopoietic Stem Cells
The marketing approval of genetically engineered hematopoietic stem cells (HSCs) as the first-line therapy for the treatment of severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID) is a tribute to the substantial progress that has been made regarding HSC engineering in t...
Сохранить в:
| Опубликовано в: : | Mol Ther Methods Clin Dev |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Gene & Cell Therapy
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5415326/ https://ncbi.nlm.nih.gov/pubmed/28480310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2017.03.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|